A citation-based method for searching scientific literature

Andrea N Traina, Michael P Kane. Diabetes Educ 2011
Times Cited: 8







List of co-cited articles
37 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Review of pramlintide as adjunctive therapy in treatment of type 1 and type 2 diabetes.
Gina Ryan, Tim A Briscoe, Lynette Jobe. Drug Des Devel Ther 2009
44
50

Glucoregulatory effects and prolonged duration of action of davalintide: a novel amylinomimetic peptide.
C M Mack, P A Smith, J R Athanacio, K Xu, J K Wilson, J M Reynolds, C M Jodka, M G W Lu, D G Parkes. Diabetes Obes Metab 2011
25
37

A novel oral form of salmon calcitonin improves glucose homeostasis and reduces body weight in diet-induced obese rats.
M Feigh, K Henriksen, K V Andreassen, C Hansen, J E Henriksen, H Beck-Nielsen, C Christiansen, M A Karsdal. Diabetes Obes Metab 2011
29
37

Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product.
G Christopoulos, K J Perry, M Morfis, N Tilakaratne, Y Gao, N J Fraser, M J Main, S M Foord, P M Sexton. Mol Pharmacol 1999
320
37

Islet amyloid polypeptide inhibits glucagon release and exerts a dual action on insulin release from isolated islets.
Björn Akesson, Georgios Panagiotidis, Per Westermark, Ingmar Lundquist. Regul Pept 2003
46
37

The role of pramlintide for weight loss.
Kaelen C Dunican, Nicole M Adams, Alicia R Desilets. Ann Pharmacother 2010
19
37

Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight.
C M Mack, C J Soares, J K Wilson, J R Athanacio, V F Turek, J L Trevaskis, J D Roth, P A Smith, B Gedulin, C M Jodka,[...]. Int J Obes (Lond) 2010
63
37

Pramlintide and the treatment of diabetes: a review of the data since its introduction.
Lisa M Younk, Maia Mikeladze, Stephen N Davis. Expert Opin Pharmacother 2011
48
37

A novel oral dual amylin and calcitonin receptor agonist (KBP-042) exerts antiobesity and antidiabetic effects in rats.
Kim V Andreassen, Michael Feigh, Sara T Hjuler, Sofie Gydesen, Jan Erik Henriksen, Henning Beck-Nielsen, Claus Christiansen, Morten A Karsdal, Kim Henriksen. Am J Physiol Endocrinol Metab 2014
32
37

The dual amylin- and calcitonin-receptor agonist KBP-042 increases insulin sensitivity and induces weight loss in rats with obesity.
Sara Toftegaard Hjuler, Sofie Gydesen, Kim Vietz Andreassen, Steffen Lund Kjaer Pedersen, Lars I Hellgren, Morten Asser Karsdal, Kim Henriksen. Obesity (Silver Spring) 2016
21
37

KBP-042 improves bodyweight and glucose homeostasis with indices of increased insulin sensitivity irrespective of route of administration.
Sara T Hjuler, Kim V Andreassen, Sofie Gydesen, Morten A Karsdal, Kim Henriksen. Eur J Pharmacol 2015
16
37

Oral salmon calcitonin attenuates hyperglycaemia and preserves pancreatic beta-cell area and function in Zucker diabetic fatty rats.
M Feigh, K V Andreassen, A V Neutzsky-Wulff, S T Petersen, C Hansen, A C Bay-Jensen, J E Henriksen, H Beck-Nielsen, C Christiansen, K Henriksen,[...]. Br J Pharmacol 2012
15
25

Measurement of protein using bicinchoninic acid.
P K Smith, R I Krohn, G T Hermanson, A K Mallia, F H Gartner, M D Provenzano, E K Fujimoto, N M Goeke, B J Olson, D C Klenk. Anal Biochem 1985
25

Dietary control of pathogenesis in C57BL/KsJ db/db diabetes mice.
E H Leiter, D L Coleman, A B Eisenstein, I Strack. Metabolism 1981
34
25

The acute effect of amylin and salmon calcitonin on energy expenditure.
Peter Y Wielinga, Bettina Alder, Thomas A Lutz. Physiol Behav 2007
42
25

Mechanisms linking obesity to insulin resistance and type 2 diabetes.
Steven E Kahn, Rebecca L Hull, Kristina M Utzschneider. Nature 2006
25

The role of amylin in the control of energy homeostasis.
Thomas A Lutz. Am J Physiol Regul Integr Comp Physiol 2010
87
25

Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle.
G J Cooper, B Leighton, G D Dimitriadis, M Parry-Billings, J M Kowalchuk, K Howland, J B Rothbard, A C Willis, K B Reid. Proc Natl Acad Sci U S A 1988
239
25

Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial.
Priscilla A Hollander, Philip Levy, Mark S Fineman, David G Maggs, Larry Z Shen, Susan A Strobel, Christian Weyer, Orville G Kolterman. Diabetes Care 2003
189
25

Pramlintide improved glycemic control and reduced weight in patients with type 2 diabetes using basal insulin.
Matthew Riddle, Juan Frias, Bei Zhang, Holly Maier, Carl Brown, Karen Lutz, Orville Kolterman. Diabetes Care 2007
66
25

Dose-response for glucagonostatic effect of amylin in rats.
B R Gedulin, T J Rink, A A Young. Metabolism 1997
109
25



Matrix synthesis and degradation in human intervertebral disc degeneration.
C L Le Maitre, A Pockert, D J Buttle, A J Freemont, J A Hoyland. Biochem Soc Trans 2007
283
25

Effect of hyperglycemia on apoptosis of notochordal cells and intervertebral disc degeneration in diabetic rats.
Ho-Yeon Won, Jong-Beom Park, Eun-Young Park, K Daniel Riew. J Neurosurg Spine 2009
51
25

Intervertebral disk nutrition: a review of factors influencing concentrations of nutrients and metabolites.
Thijs Grunhagen, Aboulfazl Shirazi-Adl, Jeremy C T Fairbank, Jill P G Urban. Orthop Clin North Am 2011
94
25


Prolonged calcitonin receptor signaling by salmon, but not human calcitonin, reveals ligand bias.
Kim Vietz Andreassen, Sara Toftegaard Hjuler, Sebastian G Furness, Patrick M Sexton, Arthur Christopoulos, Olivier Nosjean, Morten Asser Karsdal, Kim Henriksen. PLoS One 2014
36
25

The Dual Amylin and Calcitonin Receptor Agonist KBP-088 Induces Weight Loss and Improves Insulin Sensitivity Superior to Chronic Amylin Therapy.
Anna Thorsø Larsen, Nina Sonne, Kim Vietz Andreassen, Kristoffer Gehring, Morten Asser Karsdal, Kim Henriksen. J Pharmacol Exp Ther 2019
7
28

Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight.
Christine Mack, Julie Wilson, Jennifer Athanacio, James Reynolds, Kevin Laugero, Stacy Guss, Calvin Vu, Jonathan Roth, David Parkes. Am J Physiol Regul Integr Comp Physiol 2007
66
25

Optimization of tolerability and efficacy of the novel dual amylin and calcitonin receptor agonist KBP-089 through dose escalation and combination with a GLP-1 analog.
Sofie Gydesen, Kim Vietz Andreassen, Sara Toftegaard Hjuler, Lars I Hellgren, Morten Asser Karsdal, Kim Henriksen. Am J Physiol Endocrinol Metab 2017
15
25

Effects of pramlintide in patients with type 2 diabetes mellitus: an analysis using daily insulin dose tertiles.
Kathrin Herrmann, Kevin Shan, Steven C Brunell, Steve Chen. Endocr Pract 2014
5
40

Rodent models of leptin receptor deficiency are less sensitive to amylin.
Sonya Duffy, Thomas A Lutz, Christina N Boyle. Am J Physiol Regul Integr Comp Physiol 2018
13
25

KBP-088, a novel DACRA with prolonged receptor activation, is superior to davalintide in terms of efficacy on body weight.
Sofie Gydesen, Kim Vietz Andreassen, Sara Toftegaard Hjuler, Jane Marie Christensen, Morten Asser Karsdal, Kim Henriksen. Am J Physiol Endocrinol Metab 2016
19
25

The Dual Amylin- and Calcitonin-Receptor Agonist KBP-042 Works as Adjunct to Metformin on Fasting Hyperglycemia and HbA1c in a Rat Model of Type 2 Diabetes.
Sara T Hjuler, Sofie Gydesen, Kim V Andreassen, Morten A Karsdal, Kim Henriksen. J Pharmacol Exp Ther 2017
14
25

A novel dual amylin and calcitonin receptor agonist, KBP-089, induces weight loss through a reduction in fat, but not lean mass, while improving food preference.
Sofie Gydesen, Sara Toftegaard Hjuler, Zenia Freving, Kim Vietz Andreassen, Nina Sonne, Lars I Hellgren, Morten Asser Karsdal, Kim Henriksen. Br J Pharmacol 2017
24
25

Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: a phase 2, randomized, placebo-controlled, dose-escalation study.
Louis Aronne, Ken Fujioka, Vanita Aroda, Kim Chen, Amy Halseth, Nicole C Kesty, Colleen Burns, Cameron W Lush, Christian Weyer. J Clin Endocrinol Metab 2007
95
25

Molecular cloning of two receptors from rat brain with high affinity for salmon calcitonin.
K Albrandt, E Mull, E M Brady, J Herich, C X Moore, K Beaumont. FEBS Lett 1993
58
12


Selective amylin inhibition of the glucagon response to arginine is extrinsic to the pancreas.
R A Silvestre, J Rodríguez-Gallardo, C Jodka, D G Parkes, R A Pittner, A A Young, J Marco. Am J Physiol Endocrinol Metab 2001
42
12

Pharmacology, physiology, and mechanisms of incretin hormone action.
Jonathan E Campbell, Daniel J Drucker. Cell Metab 2013
683
12


Diabetes in Zucker diabetic fatty rat.
Masakazu Shiota, Richard L Printz. Methods Mol Biol 2012
49
12



Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rats.
B E Levin, A A Dunn-Meynell, B Balkan, R E Keesey. Am J Physiol 1997
366
12


Pioglitazone acutely reduces energy metabolism and insulin secretion in rats.
Julien Lamontagne, Elise Jalbert-Arsenault, Emilie Pepin, Marie-Line Peyot, Neil B Ruderman, Christopher J Nolan, Erik Joly, S R Murthy Madiraju, Vincent Poitout, Marc Prentki. Diabetes 2013
23
12


Control of energy homeostasis by amylin.
Thomas A Lutz. Cell Mol Life Sci 2012
74
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.